Industry Education Session - Optimising Treatment for JAK Inhibitor Naive Adult Myelofibrosis Patients with Moderate to Severe Anaemia: A Case-based Discussion - Sponsored by GSK
Tracks
-
| Monday, April 28, 2025 |
| 1:30 PM - 2:15 PM |
| Alsh |
Details
This is a promotional symposium organised and funded by GSK, intended for UK healthcare professionals only.
GSK invites you to join our promotional symposium led by myelofibrosis expert, Dr. Nauman Butt and Dr. Gillian Horne.
Dr. Horne will chair the meeting and lead the question and answers section of the symposium alongside Dr. Butt who will share his clinical experience on the unmet need and disease burden in adult patients who have myelofibrosis with moderate to severe anaemia. The session will include a case-based discussion on optimising treatment for JAK inhibitor naive adult myelofibrosis patients with moderate to severe anaemia within the real-world setting. GSK medicines will be discussed
Speaker
Dr. Nauman Butt
Consultant Haematologist
Clatterbridge Cancer Centre
- Consultant in Haemato-Oncology
Dr. Gillian Horne
Senior Clinical Research Fellow and Honorary
University of Glasgow
- Senior Clinical Research Fellow And Honorary Consultant
